![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
PS Puttfarcken, LL Werling and BM Cox
Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.
The effects of prolonged morphine exposure on the mu opioid receptor in 7315c pituitary tumor cell membranes have been examined. Since a low concentration of naloxone reversed the inhibition of forskolin- stimulated adenylyl cyclase induced by the mu-selective agonist, Tyr-D- Ala-Gly-MePhe-Gly-ol (DAGO), and by high concentrations of [D-Pen2-D- Pen5]enkephalin (DPDPE), we suggest that these cells contain a homogeneous population of mu opioid receptors coupled to adenylyl cyclase via a guanyl nucleotide-binding protein. Studies measuring the ability of [D-Ala2-D-Leu5]enkephalin (DADLE), an opioid agonist, to inhibit adenylyl cyclase in cells that had been exposed to 100 microM morphine for varying periods of time, indicated that the agonist no longer inhibited enzyme activity after 5 hr of morphine exposure. Measurements of 3H-antagonist binding in membranes from cells exposed to morphine demonstrated a decreased receptor density after 24 hr of 100 microM morphine exposure with no change in the antagonist affinity. Computer analysis indicated a 20% decrease in the number of mu receptors labeled after 24 hr of morphine exposure and a 60% decrease after 72 hr of exposure. Computer analysis of agonist competition against 3H-antagonist binding confirmed the existence of one binding site with an affinity intermediate between the high and low apparent affinity states observed in membranes from untreated cells. Addition of 10 microM GTP gamma S did not affect the agonist affinity or receptor density in membranes from morphine-treated cells, suggesting that the receptors were uncoupled from G proteins, as observed in 7315c cell membranes that have been treated with pertussis toxin. Thus chronic morphine treatment induced a rapid loss of opioid mu receptor-mediated inhibition of adenylyl cyclase (desensitization), and a more slowly developing reduction in receptor number. The desensitization was accompanied by a loss of guanyl nucleotide regulation of agonist affinity. These findings are comparable to results reported for the delta opioid receptor and the beta-adrenergic receptor upon prolonged agonist exposure.
This article has been cited by other articles:
|
|
 |
|
  A. Breit, K. Gagnidze, L. A. Devi, M. Lagace, and M. Bouvier Simultaneous Activation of the {delta} Opioid Receptor ({delta}OR)/Sensory Neuron-Specific Receptor-4 (SNSR-4) Hetero-Oligomer by the Mixed Bivalent Agonist Bovine Adrenal Medulla Peptide 22 Activates SNSR-4 but Inhibits {delta}OR Signaling Mol. Pharmacol., August 1, 2006; 70(2): 686 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. McLaughlin, M. Xu, K. Mackie, and C. Chavkin Phosphorylation of a Carboxyl-terminal Serine within the {kappa}-Opioid Receptor Produces Desensitization and Internalization J. Biol. Chem., September 5, 2003; 278(36): 34631 - 34640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Szeto, Y. Soong, D. Wu, and J. Fasolo Resensitization of Blood Pressure Response to {micro}-Opioid Peptide Agonists After Acute Desensitization Anesth. Analg., September 1, 2001; 93(3): 581 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Williams, M. J. Christie, and O. Manzoni Cellular and Synaptic Adaptations Mediating Opioid Dependence Physiol Rev, January 1, 2001; 81(1): 299 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Sim-Selley, D. E. Selley, L. J. Vogt, S. R. Childers, and T. J. Martin Chronic Heroin Self-Administration Desensitizes {micro} Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain J. Neurosci., June 15, 2000; 20(12): 4555 - 4562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. El Kouhen, O. M.-E. Kouhen, P.-Y. Law, and H. H. Loh The Absence of a Direct Correlation between the Loss of [D-Ala2,MePhe4,Gly5-ol]Enkephalin Inhibition of Adenylyl Cyclase Activity and Agonist-induced µ-Opioid Receptor Phosphorylation J. Biol. Chem., April 2, 1999; 274(14): 9207 - 9215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shoji, J. Delfs, and J. T. Williams Presynaptic Inhibition of GABAB-Mediated Synaptic Potentials in the Ventral Tegmental Area during Morphine Withdrawal J. Neurosci., March 15, 1999; 19(6): 2347 - 2355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Ingram, C. W. Vaughan, E. E. Bagley, M. Connor, and M. J. Christie Enhanced Opioid Efficacy in Opioid Dependence Is Caused by an Altered Signal Transduction Pathway J. Neurosci., December 15, 1998; 18(24): 10269 - 10276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chieng and J. T. Williams Increased Opioid Inhibition of GABA Release in Nucleus Accumbens during Morphine Withdrawal J. Neurosci., September 1, 1998; 18(17): 7033 - 7039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhu, L.-Y. Luo, G.-F. Mao, B. Ashby, and L.-Y. Liu-Chen Agonist-Induced Desensitization and Down-regulation of the Human Kappa Opioid Receptor Expressed in Chinese Hamster Ovary Cells J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 28 - 36. [Abstract] [Full Text]
|
|
|
|
|
|
J. Y. Xu, K. P. Hill, and J. M. Bidlack The Nitric Oxide/Cyclic GMP System at the Supraspinal Site Is Involved in the Development of Acute Morphine Antinociceptive Tolerance, J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 196 - 201. [Abstract] [Full Text]
|
|
|
|
|
|
F. Noble and B. M. Cox The Role of Dopaminergic Systems in Opioid Receptor Desensitization in Nucleus Accumbens and Caudate Putamen of Rat After Chronic Morphine Treatment J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 557 - 565. [Abstract] [Full Text]
|
|
|
|
|
|
A. Bonci and J. T. Williams Increased Probability of GABA Release during Withdrawal from Morphine J. Neurosci., January 15, 1997; 17(2): 796 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
AllanD. Blake, G. Bot, JohnC. Freeman, and T. Reisine Differential Opioid Agonist Regulation of the MouseµOpioid Receptor J. Biol. Chem., January 10, 1997; 272(2): 782 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chieng and M. J. Christie Local Opioid Withdrawal in Rat Single Periaqueductal Gray Neurons In Vitro J. Neurosci., November 15, 1996; 16(22): 7128 - 7136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Avidor-Reiss, M. Bayewitch, R. Levy, N. Matus-Leibovitch, I. Nevo, and Z. Vogel Adenylylcyclase Supersensitization in µ-Opioid Receptor-transfected Chinese Hamster Ovary Cells Following Chronic Opioid Treatment J. Biol. Chem., December 15, 1995; 270(50): 29732 - 29738. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
